{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:17Z","timestamp":1761100997382,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1866,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.bbmt.2009.10.007","type":"journal-article","created":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T04:30:24Z","timestamp":1255581024000},"page":"333-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["An Age-Dependent Pharmacokinetic Study of Intravenous and Oral Mycophenolate Mofetil in Combination with Tacrolimus for GVHD Prophylaxis in Pediatric Allogeneic Stem Cell Transplantation Recipients"],"prefix":"10.1016","volume":"16","author":[{"given":"Monica","family":"Bhatia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Militano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhezhen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Figurski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford","family":"Tallamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmella","family":"van deVen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Ayello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LeeAnn","family":"Baxter-Lowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash","family":"Satwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Brigid","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Garvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell S.","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2009.10.007_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.bmt.1705992","article-title":"Pediatric blood and marrow transplantation: state of the science","volume":"41","author":"Cairo","year":"2008","journal-title":"Bone Marrow Transplant"},{"year":"1999","author":"Chao","series-title":"Graft Versus Host Disease","key":"10.1016\/j.bbmt.2009.10.007_bib2"},{"key":"10.1016\/j.bbmt.2009.10.007_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1083-8791(99)70011-X","article-title":"Pathophysiologic mechanisms of acute graft-vs.-host disease","volume":"5","author":"Ferrara","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.007_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bmt.1705885","article-title":"Acute graft-versus-host disease in children","volume":"41","author":"Jacobsohn","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.007_bib5","first-page":"137","article-title":"Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia","volume":"6","author":"Mrsic","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.007_bib6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2009.10.007_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00007890-198702000-00020","article-title":"Exacerbation of cyclosporine toxicity by concomitant administration of erythromycin","volume":"43","author":"Jensen","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.10.007_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood.V64.1.215.215","article-title":"Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients","volume":"64","author":"Lazarus","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.10.007_bib9","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(84)91556-3","article-title":"Association between cyclosporin neurotoxicity and hypomagnesaemia","volume":"2","author":"Thompson","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2009.10.007_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0008-8749(91)90103-I","article-title":"FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes","volume":"133","author":"Lin","year":"1991","journal-title":"Cell Immunol"},{"key":"10.1016\/j.bbmt.2009.10.007_bib11","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2165\/00003495-199346040-00009","article-title":"Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation","volume":"46","author":"Peters","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.bbmt.2009.10.007_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bmt.1703097","article-title":"Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation","volume":"28","author":"Hiraoka","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.007_bib13","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors","volume":"96","author":"Nash","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.10.007_bib14","first-page":"2303","article-title":"Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation","volume":"92","author":"Ratanatharathorn","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.10.007_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.bmt.1701281","article-title":"Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients","volume":"22","author":"Basara","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.007_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00007890-199902270-00001","article-title":"Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation","volume":"67","author":"Bornhauser","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.10.007_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bmt.1705422","article-title":"Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus","volume":"38","author":"Dvorak","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.007_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/bmt.2008.85","article-title":"Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation","volume":"42","author":"Haentzschel","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.007_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.bmt.1704640","article-title":"Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation","volume":"34","author":"Mohty","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.007_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbmt.2003.11.005","article-title":"A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients","volume":"10","author":"Osunkwo","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.007_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00262-004-0614-9","article-title":"Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model","volume":"54","author":"Shapira","year":"2005","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.bbmt.2009.10.007_bib22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.10.007_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4347(95)00343-6","article-title":"Manual and automated (robotic) high-performance liquid chromatography methods for the determination of mycophenolic acid and its glucuronide conjugate in human plasma","volume":"675","author":"Tsina","year":"1996","journal-title":"J Chromatogr"},{"key":"10.1016\/j.bbmt.2009.10.007_bib24","first-page":"511","article-title":"HPLC-MS\/MS method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites","volume":"29","author":"Figurski","year":"2007","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.bbmt.2009.10.007_bib25","series-title":"Biopharmaceutics and Clinical Pharmacokinetics","article-title":"Biopharmaceutics and Clinical Pharmacokinetics","author":"Gibaldi","year":"1984"},{"key":"10.1016\/j.bbmt.2009.10.007_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0091270007313326","article-title":"Higher mycophenolate dose requirements in children undergoing hematopoietic cell transplant (HCT)","volume":"48","author":"Jacobson","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.bbmt.2009.10.007_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbmt.2005.03.006","article-title":"A phase I\/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation","volume":"11","author":"Nash","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.007_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/106689690301100406","article-title":"Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern","volume":"11","author":"Papadimitriou","year":"2003","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.bbmt.2009.10.007_bib29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.bbmt.2007.05.011","article-title":"Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning","volume":"13","author":"Baron","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.10.007_bib30","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1182\/blood-2005-06-2217","article-title":"Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation","volume":"106","author":"Giaccone","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.10.007_bib31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1034\/j.1399-0012.2001.150306.x","article-title":"Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation","volume":"15","author":"Jenke","year":"2001","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2009.10.007_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/j.1552-4604.1996.tb04207.x","article-title":"Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration","volume":"36","author":"Bullingham","year":"1996","journal-title":"J\u00a0Clinl Pharmacol"},{"key":"10.1016\/j.bbmt.2009.10.007_bib33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00007691-200108000-00001","article-title":"Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion","volume":"23","author":"Shaw","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.bbmt.2009.10.007_bib34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1034\/j.1600-6143.2003.00079.x","article-title":"Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies","volume":"3","author":"Shaw","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2009.10.007_bib35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/j.1552-4604.1998.tb04424.x","article-title":"Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function","volume":"38","author":"Shaw","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.bbmt.2009.10.007_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2710.2008.00906.x","article-title":"No pharmacokinetic interactions between mycophenolic acid and tacrolimus in renal transplant recipients","volume":"33","author":"Kagaya","year":"2008","journal-title":"J Clin Pharmacy Therapeut"},{"key":"10.1016\/j.bbmt.2009.10.007_bib37","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1097\/01.tp.0000186380.61251.fc","article-title":"The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation","volume":"80","author":"van Gelder","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.10.007_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bbmt.2009.10.007_bib39","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/01.tp.0000232697.38021.9a","article-title":"Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature","volume":"82","author":"Arns","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.10.007_bib40","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00007890-199911270-00028","article-title":"Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients","volume":"68","author":"Gregoor","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.10.007_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007691-200408000-00002","article-title":"Using established immunosuppressant therapy effectively: lessons from the measurement of mycophenolic acid plasma concentrations","volume":"26","author":"Shaw","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.bbmt.2009.10.007_bib42","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/FTD.0b013e31818b6b2f","article-title":"Suboptimal aminoglycoside dosing in critically ill patients","volume":"30","author":"Rea","year":"2008","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.bbmt.2009.10.007_bib43","first-page":"271","article-title":"Metabolic alterations in sepsis and vasoactive drug-related metabolic effects","volume":"9","author":"Trager","year":"2003","journal-title":"Curr Opin Crit Care"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109004637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109004637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:36:07Z","timestamp":1761057367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879109004637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1083879109004637"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.10.007","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Age-Dependent Pharmacokinetic Study of Intravenous and Oral Mycophenolate Mofetil in Combination with Tacrolimus for GVHD Prophylaxis in Pediatric Allogeneic Stem Cell Transplantation Recipients","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}